Clinique extends redness relief line
New Redness Relief Instant Relief Mineral Pressed Powder is said to neutralise visible redness, while keeping skin cool and comfortable. The yellow shade has been custom-created by Clinique to help even out blotchy red skin and broken capillaries leaving skin looking even.
The formula contains caffeine, magnolia bark, mushroom and grapefruit peel extracts, along with a mineral blend. Vitamin E and colour correctors neutralise redness.
Also new is Redness Solutions Makeup SPF 15 with Probiotic Technology, a liquid foundation treatment. The product contains neutralising pearls with a yellow-green undertone which help camouflage redness. In addition, Clinique has added an extract of cultured Lactobacillus plantarum to strengthen the skin’s barrier. Six shades are available.
Finally Clinique has created Redness Solutions Corrector, a yellow-hued concealer.
You may also like
Trending Articles
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Vichy’s longevity science play addresses hair loss and zombie cells
Hair renewing serum Dercos Aminexil Clinical R.E.G.E.N. Booster, and Neovadiol Longevity Revolumizing Cream for boomers, are the L’Oréal-owned dermatological brand’s first longevity-focused launches, and more are in the pipeline
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
The three types of science-savvy skin care consumers set to drive €4bn of beauty sales growth
‘Clinical Seekers’, ‘Skin Care Hackers’ and ‘Effortless Quality Enthusiasts’ value clinical efficacy but are not necessarily loyal to brands in their multi-step routines, according to a new report by L.E.K Consulting
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.